Orthobiogen's south Tulsa clinic, part of the Regenexx network, offering injections of the patient's own bone marrow concentrate and platelet rich plasma for joint and spine problems.
This is the south Tulsa site of Orthobiogen, a non-surgical orthopaedic practice that describes itself as Oklahoma's only Regenexx provider. Regenexx is a national network with standardised protocols for preparing injections from a patient's own tissue. The clinic is at 717 West 71st Street, south Tulsa, and shares its physician with the practice's Oklahoma City site.
The treatments offered are Regenexx bone marrow procedures, Regenexx platelet rich plasma (PRP, prepared from the patient's own blood) and prolotherapy. The practice states that the material injected comes from the patient themselves: platelet rich plasma, and bone marrow concentrate which it describes as containing the patient's own live stem cells. This is an entirely autologous approach, meaning everything injected comes from the patient's own body. No donor, umbilical cord, amniotic or other birth tissue products are named anywhere on the pages reviewed, which distinguishes this practice from many clinics in the same field.
The conditions listed are musculoskeletal and spinal: knee problems including anterior cruciate ligament and meniscus tears and osteoarthritis; spinal problems including herniated and bulging discs, stenosis and neck pain; shoulder problems including rotator cuff and labral tears; hip osteoarthritis and labral and tendon tears; hand and wrist problems including carpal tunnel syndrome and triangular fibrocartilage complex tears; foot and ankle ligament and tendon tears; and tennis and golfer's elbow. The site presents these treatments as a way to avoid or delay surgery and shorten recovery. That is the practice's own framing and no outcome figures are published.
The named physician is Keley John Booth, MD, described as a native Oklahoman with 15 years of clinical experience in pain management and musculoskeletal injury. The south Tulsa site's hours are given as Monday to Friday, 9am to 5pm, and the page notes these are for evaluation appointments, which suggests procedures may be carried out elsewhere; that is worth confirming. No prices are published and the site does not state what insurance covers.
The practice organises its pages by body area; the conditions below are those it names for this location.
The site states that its Regenexx procedures use the patient's own tissue, specifically bone marrow concentrate described as containing the patient's own live stem cells, and platelet rich plasma.
One physician is named, working across both of the practice's Oklahoma sites.
The clinic is at 717 West 71st Street in south Tulsa and is the smaller of Orthobiogen's two Oklahoma sites, the main office being in Oklahoma City. The practice as a whole describes on-site high-frequency ultrasound, electromyography and digital spinal fluoroscopy for diagnosis and injection guidance. The south Tulsa page gives hours of Monday to Friday, 9am to 5pm and specifies that these are evaluation appointments, so a patient should confirm where any procedure itself would be carried out. No laboratory accreditation is stated.
No prices are published for this location. The practice directs patients towards insurance information without saying what is covered, and Regenexx-type procedures are commonly paid for privately. A consultation would be needed to obtain a figure.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.